Le Lézard
Classified in: Health
Subject: PER

Vitalah® Creators of Oxylent® Welcomes Tom Tierney as their New President


SANTA CRUZ COUNTY, Calif., Feb. 19, 2018 /PRNewswire/ -- Vitalah®, the Proud Creators of Oxylent® (www.oxylent.com), is excited to announce Mr. Tom Tierney as their new President. Tierney has an extensive sales background in a wide range of business categories and channels. "We are very proud to have Tom join our executive team. His prominent business background and adaptable leadership style has generated thriving enterprises across multiple retail channels and we are excited to start implementing his strategic plans into our organization. Our entire team here at Oxylent® is looking forward to a successful future with Tom on board," says Founder and CEO, Lisa Lent.  

In his most recent endeavor at Amazing Grass, Tierney was recruited to join the entrepreneurial business at its infancy and organized the launch of an organic supplement product line in the natural product channel, e-tail channel and crossover FDM retailers. Responsible for managing direct sales representatives, brokers and international distributors, his leadership role focused on establishing strategic retail partnerships, building sales infrastructure and recruiting and managing a high performance sales team. Amazing Grass was successfully acquired by Glanbia in January 2017.  

Now equipped with over 30 years of experience, Tierney has joined the Oxylent® team with high expectations and sales goals. Tierney states, "I am pleased to join the Oxylent® team. For the past 9 years, the brand has continuously received multiple awards and recognition for their superior quality and formulations. Now that is a reputation I can proudly stand behind. I'm truly impressed by the owner's immense passion and determination for the brand as well as a strong team of individuals who possess the qualities necessary to create a successful operation. I'm looking forward to being a part of a team of outstanding individuals and supporting the growth of Oxylent®."  

About Vitalah®  

Vitalah® was founded by Lisa Lent as an "invitation to health" born from her passion to create the ultimate supplement for everyday life. Vitalah®'s flagship product, Oxylent®, is an effervescent multivitamin drink containing a unique blend of essential nutrients that enable the body to function at peak levels.  

Purchasing Oxylent® products also supports Vitamin Angels®?a global non-profit organization that provides under-nourished children with nutritional supplements.  

Oxylent® formulas are available nationwide at major natural food retailers including Whole Foods, The Vitamin Shoppe, Sprouts, Fresh Thyme and online at oxylent.com. For more information on Oxylent®'s incredible line of products, visit www.oxylent.com or call 877.OXYLENT (877.699.5368).  

Find Oxylent® on Facebook at www.facebook.com/oxylent, on Twitter @oxylent and on Instagram @drinkoxylentbreathelife.  

CONTACT:  [email protected]

SOURCE Vitalah


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: